| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RHD | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-05 |
| mRNA | MPP1 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-05 |
| mRNA | GYPE | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | NATD1 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | TUBB1 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-05 |
| mRNA | CA1 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | MXD1 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-05 |
| mRNA | ZSCAN4 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-05 |
| mRNA | ERI2 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-05 |
| mRNA | HEMGN | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-05 |
